Search results
Results From The WOW.Com Content Network
Kite Pharma, Inc. is an American biotechnology ... a 29% premium on the share price ... of its common stock. [45] In June 2014, Kite Pharma sold 8,625,000 shares of ...
The stock is up nearly 6% Thursday, trading at more than $96 per share, compared to a market close price of $91.69 per share. ... That includes the $12 billion acquisition of Kite Pharma ...
In April 2014, Kite Pharma completed a $50 million mezzanine private financing of convertible notes, [9] and in May, the company filed a registration with the SEC for an IPO of its common stock, with a proposed maximum offering price of $115 million. The company listed on the NASDAQ Global Market under the symbol "KITE."
In August 2017, the company announced it would acquire Kite Pharma for $11.9 billion, [55] equating to $180 cash per share, a 29% premium over the closing price of the shares. The deal was Gilead's entry into the cell therapy market and added a chimeric antigen receptor T cell ( CAR-T ) therapy candidate to the company's portfolio. [ 56 ]
Valeant Pharmaceuticals: Allergan, Inc: 53.3 71 Valeant raised its unsolicited offer for Allergan a second time, to $53.3 billion, increasing the cash portion of the bid in an effort to win the backing of the company, with the cash-and-stock portion of the bid valuing each Allergan share at $179.25. [26] 16 2014 Valeant Pharmaceuticals ...
The Sharon L. Allen Stock Index From August 2012 to December 2012, if you bought shares in companies when Sharon L. Allen joined the board, and sold them when she left, you would have a 60.8 percent return on your investment, compared to a 3.7 percent return from the S&P 500.
Eli Lilly’s stock price is riding a wave of optimism and strong earnings. ... What’s been driving the pharma giant’s share price higher? Rachel Christian. June 12, 2024 at 9:06 AM.
With the biotech company's stock already posting impressive gains of over 9% in early 2025, it's worth examining whether Vertex stock remains a compelling buy right now. Life sciences researcher ...